Related Recommend
|
Product Name |
Flumequine |
||
|
Applications |
Mainly used in the treatment of metastatic castration - resistant prostate cancer to inhibit the synthesis of androgens and slow down cancer progression. |
||
|
Typical Properties |
Appearance |
White or almost white crystalline powder, odorless |
|
|
Specific rotation |
-0.10 0~+0.10 |
||
|
Distinguish |
TLC |
positive reaction |
|
|
IR |
Conforms to that of the standard solution |
||
|
Clarity and color of solution |
Should be confirm |
||
|
Loss on drying(%) |
≤0.5% |
||
|
Residue On Ignition(%) |
≤0.1% |
||
|
Heavy metal |
≤10ppm |
||
|
Total impurity,% |
≤1.0% |
||
|
Any other impurity |
≤0.5% |
||
|
Assay,% |
≥99.1% |
||
|
Product Name |
Flumequine |
||
|
Applications |
Mainly used in the treatment of metastatic castration - resistant prostate cancer to inhibit the synthesis of androgens and slow down cancer progression. |
||
|
Typical Properties |
Appearance |
White or almost white crystalline powder, odorless |
|
|
Specific rotation |
-0.10 0~+0.10 |
||
|
Distinguish |
TLC |
positive reaction |
|
|
IR |
Conforms to that of the standard solution |
||
|
Clarity and color of solution |
Should be confirm |
||
|
Loss on drying(%) |
≤0.5% |
||
|
Residue On Ignition(%) |
≤0.1% |
||
|
Heavy metal |
≤10ppm |
||
|
Total impurity,% |
≤1.0% |
||
|
Any other impurity |
≤0.5% |
||
|
Assay,% |
≥99.1% |
||